Produção Nacional
Revisado por pares
May Measurement Month 2018: an analysis of blood pressure screening results from Brazil
2020; Oxford University Press; Volume: 22; Issue: Supplement_H Linguagem: Inglês
10.1093/eurheartj/suaa022
ISSN1554-2815
AutoresEduardo Costa Duarte Barbosa, Bruna Eibel, Audes D. M. Feitosa, Andréa Araújo Brandão, Luiz Aparecido Bortolotto, Mário Fritsch Neves, José Fernando Vilela-Martin, Antonio C S Spinelli, Elizabeth E S Cestário, Érika Maria Gonçalves Campana, Juan Carlos Yugar‐Toledo, Rui Póvoa, Thomas Beaney, Anca Chis Ster, Neil R Poulter, Marco Antônio Mota Gomes, Weimar Kunz Sebba Barroso,
Tópico(s)Sodium Intake and Health
ResumoAbstract Hypertension is a pathology of high prevalence in the world. In Brazil, it is the main risk factor for the major cause of death in the country, coronary heart disease. The May Measurement Month Campaign in 2018 (MMM18) included a population with representation from all Brazilian states and reflects some of the characteristics of hypertension in Brazil. Questionnaire data were collected and three measures of blood pressure (BP) were performed. The sample consisted of 12 413 individuals, 59.1% were white, 51.3% were women. The average age was 54. ± 16.0 years. Diabetes was present in 11.6%, previous myocardial infarction in 5.9%, and previous stroke in 2.7%. Current smokers were 9.3% and 12.4% were regular drinkers. The average body mass index was 27.3 ± 4.5 kg/m2. After multiple imputations, 67.9% were hypertensive (>140/90 mmHg). Of the individuals who were not taking antihypertensive medication, 27.9% were hypertensive and of those taking antihypertensive medication, 40.3% were uncontrolled. Systolic BP increased with age. The MMM18 campaign demonstrated a large number of unknown hypertensives and a high rate of uncontrolled hypertension in Brazil, unfortunately in keeping with 2017 findings.
Referência(s)